TP53 and glioblastoma: Therefore, we employed the cerebral organoids derived from hPSCs, and to enhance the sensitivity for detecting potential risk cells in cell products, we generated glioblastoma-like organoids (GBM organoid) from TP53−/−/PTEN−/− hPSCs.